BankNordik has now fully distributed excess capital from the sale of its Danish business – one year ...
Redeye’s expectations on the Q1 numbers were rather modest as Heliospectra is in a transitional phas...
Cline Scientific (”Cline” eller ”Bolaget”) har genom egenutvecklad och patenterad teknologi just nu ...
Q1-rapporten Hansa släppte igår sin rapport för det första kvartalet 2022.
Stark tillväxt Bolagets verksamhetsuppdatering för Q1 2022 (full rapportering sker på halvårsbasis) ...
Stark resultatutveckling i Q1'22 BE Group levererade ett underliggande rörelseresultat på 180 mkr i ...
Vitrolife’s previous Q1 confirms more normal activity with improved organic growth to 11% from the l...
The first quarter was slow in terms of sales as no system sales were recorded.
Redeye comments on Active Biotech’s first quarter report and updates its valuation and forecast.
Plejd fortsätter växa i hög takt med ständigt förbättrad lönsamhet.
Lucky Games, som designar, utvecklar och marknadsför kasinospel med olika teman och underhållningsvä...
Scanfil’s Q1 top line continued to grow at a 20% annual rate while operating margin remained decent ...
Evli and EAB have signed a letter of intent, pursuant to which the parties are looking into a potent...
Scanfil reported better net sales and better EBIT than market consensus (Refinitiv) expected in Q1.
Elanders presented a strong Q1 report with 2% group organic growth but EBIT growing by 29% y/y, whic...
SDS publicerade idag den 21 april 2022 bolagets delårsrapport för det första kvartalet 2022.
Idefirix has secured pricing and reimbursement in Sweden, the Netherlands and Germany, and on an ind...
Redeye expects to lower its fair value range thanks to soft sales, which were hurt by some delayed o...
Finnair reports Q1 results on Apr 27. The focus will be on the responses to the change which alters ...
Indexuppräkning i kombination med bra nettouthyrning medför stark tillväxt i hyresintäkterna inför 2...
